Trial Title:
Chemotherapy Combined With Immunotherapy vs Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
NCT ID:
NCT06096844
Condition:
Advanced Lung Non-Small Cell Carcinoma
Stage IIIB Lung Cancer AJCC v8
Stage IIIC Lung Cancer AJCC v8
Stage IV Lung Cancer AJCC v8
Conditions: Official terms:
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Paclitaxel
Albumin-Bound Paclitaxel
Carboplatin
Pembrolizumab
Pemetrexed
Study type:
Interventional
Study phase:
Phase 3
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
Biospecimen Collection
Description:
Undergo stool sample collection
Arm group label:
Arm A (pembrolizumab)
Arm group label:
Arm B (pembrolizumab, chemotherapy)
Other name:
Biological Sample Collection
Other name:
Biospecimen Collected
Other name:
Specimen Collection
Intervention type:
Drug
Intervention name:
Carboplatin
Description:
Given IV
Arm group label:
Arm B (pembrolizumab, chemotherapy)
Other name:
Blastocarb
Other name:
Carboplat
Other name:
Carboplatin Hexal
Other name:
Carboplatino
Other name:
Carboplatinum
Other name:
Carbosin
Other name:
Carbosol
Other name:
Carbotec
Other name:
CBDCA
Other name:
Displata
Other name:
Ercar
Other name:
JM-8
Other name:
JM8
Other name:
Nealorin
Other name:
Novoplatinum
Other name:
Paraplatin
Other name:
Paraplatin AQ
Other name:
Paraplatine
Other name:
Platinwas
Other name:
Ribocarbo
Intervention type:
Procedure
Intervention name:
Computed Tomography
Description:
Undergo CT scan
Arm group label:
Arm A (pembrolizumab)
Arm group label:
Arm B (pembrolizumab, chemotherapy)
Other name:
CAT
Other name:
CAT Scan
Other name:
Computed Axial Tomography
Other name:
Computerized Axial Tomography
Other name:
Computerized axial tomography (procedure)
Other name:
Computerized Tomography
Other name:
Computerized Tomography (CT) scan
Other name:
CT
Other name:
CT Scan
Other name:
tomography
Intervention type:
Procedure
Intervention name:
Magnetic Resonance Imaging
Description:
Undergo MRI
Arm group label:
Arm A (pembrolizumab)
Arm group label:
Arm B (pembrolizumab, chemotherapy)
Other name:
Magnetic Resonance
Other name:
Magnetic Resonance Imaging (MRI)
Other name:
Magnetic resonance imaging (procedure)
Other name:
Magnetic Resonance Imaging Scan
Other name:
Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance
Other name:
MR
Other name:
MR Imaging
Other name:
MRI
Other name:
MRI Scan
Other name:
MRIs
Other name:
NMR Imaging
Other name:
NMRI
Other name:
Nuclear Magnetic Resonance Imaging
Other name:
sMRI
Other name:
Structural MRI
Intervention type:
Drug
Intervention name:
Nab-paclitaxel
Description:
Given IV
Arm group label:
Arm B (pembrolizumab, chemotherapy)
Other name:
ABI 007
Other name:
ABI-007
Other name:
ABI007
Other name:
Abraxane
Other name:
Albumin-bound Paclitaxel
Other name:
Albumin-Stabilized Nanoparticle Paclitaxel
Other name:
Nanoparticle Albumin-bound Paclitaxel
Other name:
Nanoparticle Paclitaxel
Other name:
Naveruclif
Other name:
Paclitaxel Albumin
Other name:
paclitaxel albumin-stabilized nanoparticle formulation
Other name:
Paclitaxel Nanoparticle Albumin-bound
Other name:
Paclitaxel Protein-Bound
Other name:
Protein-bound Paclitaxel
Intervention type:
Drug
Intervention name:
Paclitaxel
Description:
Given IV
Arm group label:
Arm B (pembrolizumab, chemotherapy)
Other name:
Anzatax
Other name:
Asotax
Other name:
Bristaxol
Other name:
Praxel
Other name:
Taxol
Other name:
Taxol Konzentrat
Intervention type:
Biological
Intervention name:
Pembrolizumab
Description:
Given IV
Arm group label:
Arm A (pembrolizumab)
Arm group label:
Arm B (pembrolizumab, chemotherapy)
Other name:
BCD-201
Other name:
GME 751
Other name:
GME751
Other name:
Keytruda
Other name:
Lambrolizumab
Other name:
MK 3475
Other name:
MK-3475
Other name:
MK3475
Other name:
Pembrolizumab Biosimilar BCD-201
Other name:
Pembrolizumab Biosimilar GME751
Other name:
Pembrolizumab Biosimilar QL2107
Other name:
QL2107
Other name:
SCH 900475
Other name:
SCH-900475
Other name:
SCH900475
Intervention type:
Drug
Intervention name:
Pemetrexed
Description:
Given IV
Arm group label:
Arm B (pembrolizumab, chemotherapy)
Other name:
MTA
Other name:
Multitargeted Antifolate
Other name:
Pemfexy
Intervention type:
Procedure
Intervention name:
Positron Emission Tomography
Description:
Undergo PET
Arm group label:
Arm A (pembrolizumab)
Arm group label:
Arm B (pembrolizumab, chemotherapy)
Other name:
Medical Imaging, Positron Emission Tomography
Other name:
PET
Other name:
PET Scan
Other name:
Positron emission tomography (procedure)
Other name:
Positron Emission Tomography Scan
Other name:
Positron-Emission Tomography
Other name:
proton magnetic resonance spectroscopic imaging
Other name:
PT
Intervention type:
Other
Intervention name:
Quality-of-Life Assessment
Description:
Ancillary studies
Arm group label:
Arm A (pembrolizumab)
Arm group label:
Arm B (pembrolizumab, chemotherapy)
Other name:
Quality of Life Assessment
Intervention type:
Other
Intervention name:
Questionnaire Administration
Description:
Ancillary studies
Arm group label:
Arm A (pembrolizumab)
Arm group label:
Arm B (pembrolizumab, chemotherapy)
Summary:
This phase III trial compares the effect of adding chemotherapy to immunotherapy
(pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung
cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the
body's immune system attack the cancer, and may interfere with the ability of tumor cells
to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor
cells, either by killing the cells, by stopping them from dividing, or by stopping them
from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Detailed description:
PRIMARY OBJECTIVE:
I. To evaluate whether there is an improvement in overall survival (OS) with chemotherapy
combined with pembrolizumab compared to single agent pembrolizumab in this vulnerable
older adult patient population.
SECONDARY OBJECTIVES:
I. To evaluate any difference in progression free survival (PFS) with chemotherapy
combined with pembrolizumab as compared to single agent pembrolizumab.
II. To evaluate the difference in PFS rate at 3 months and at 6 months with chemotherapy
combined with pembrolizumab as compared to single agent pembrolizumab.
III. To evaluate the difference in best objective response rate using Response Evaluation
Criteria in Solid Tumors (RECIST) 1.1 criteria to assess whether chemotherapy combined
with pembrolizumab results in improved response rates compared to treatment with single
agent pembrolizumab.
IV. To evaluate toxicity in those treated with chemotherapy combined with pembrolizumab
compared to those treated with single agent pembrolizumab.
V. To evaluate patient reported quality of life (QOL) evaluations between treatment arms.
EXPLORATORY OBJECTIVES:
I. To compare safety and tolerability between treatment arms including but not limited to
number of additional lab draws, scan appointments, infusion visits, falls, emergency
department visits, and hospitalization related to treatment toxicity.
II. To explore factors within the pre-treatment geriatric assessment (GA) as predictors
of toxicity and outcomes. To describe changes between the intended chemotherapy treatment
planned versus treatment given and referrals placed by treating provider based on GA
results.
III. To evaluate the assessment of a novel, composite fPFS score using disease
progression/functional impairment assessment as a potential correlate to OS in this
vulnerable population.
IV. To evaluate the correlation of 3-months PFS with OS as a potential surrogate of OS
benefit.
V. To evaluate the correlation of 6-months PFS with OS as a potential surrogate of OS
benefit.
VI. To assess elective dose intensity of chemotherapy of patients who receive doublet
chemotherapy versus single agent chemotherapy.
EXPLORATORY CORRELATIVE OBJECTIVE:
I. To relate gut microbe abundances to treatment outcomes, toxicity, and geriatric
assessments.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM A:
INDUCTION: Patients receive pembrolizumab intravenously (IV) over 30 minutes on day 1 of
each cycle. Treatment repeats every 21 days for 4 cycles in the absence of disease
progression or unacceptable toxicity.
MAINTENANCE: Patients receive pembrolizumab IV over 30 minutes on day 1 of each cycle.
Cycles repeat every 21 or 42 days for 2 years in the absence of disease progression or
unacceptable toxicity.
ARM B:
INDUCTION: Patients receive pembrolizumab IV over 30 minutes on day 1 of each cycle.
Patients also receive investigator's choice of a chemotherapy regimen: 1) Pemetrexed IV
over 10 minutes + carboplatin IV over 30-60 minutes on day 1 of each cycle; 2)
Nab-paclitaxel IV over 30 on days 1, 8, and 15 of each cycle + carboplatin IV over 30-60
minutes on day 1 of each cycle; 3) Paclitaxel IV over 1 hour on day 1, 8, and 15 of each
cycle or over 3 hours on day 1 of each cycle + carboplatin IV over 30-60 minutes on day 1
of each cycle; 4) Nab-paclitaxel IV over 30 minutes on days 1, 8 and 15 of each cycle; 5)
Paclitaxel IV over 3 hours on day 1 of each cycle or over 1 hour on days 1, 8, and 15 of
each cycle; or 6) Pemetrexed IV over 10 minutes on day 1 of each cycle. Treatment repeats
every 21 days for 4 cycles in the absence of disease progression or unacceptable
toxicity.
MAINTENANCE: Patients receive pembrolizumab IV over 30 minutes on day 1 of each cycle.
Cycles repeat every 21 or 42 days for 2 years in the absence of disease progression or
unacceptable toxicity.
All patients undergo magnetic resonance imaging (MRI) at baseline and computed tomography
(CT) and/or positron emission tomography (PET) on the trial at baseline and throughout
the trial. Patients may also undergo stool sample collection at baseline and on the
trial.
After completion of study treatment, patients are followed up every 3 months if < 2 years
from randomization and every 6 months if 2-5 years from Step 1 registration.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- STEP 1 REGISTRATION
- Patient must be ≥ 70 years of age
- Patient must have histologically or cytologically confirmed non-small cell lung
cancer (NSCLC) with PD-L1 Tumor Proportion Score (TPS) range of 1-49%
- Patient must have Stage IIIB, IIIC or IV disease and not be candidates for combined
chemo-radiation. NOTE: Prior chemo-radiation therapy (RT) for stage III with
recurrence is allowed
- Patient must have a tumor that is negative for EGFR mutation/ALK translocations or
other actionable first line mutations in which patients would receive first-line
oral tyrosine kinase inhibitors
- Patient must have an Eastern Cooperative Oncology Group (ECOG) Performance Status of
2
- Patient must agree not to father children while on study and for 6 months after the
last dose of protocol treatment
- Patient must have the ability to understand and the willingness to sign a written
informed consent document. Patients with impaired decision-making capacity (IDMC)
who have a legally authorized representative (LAR) or caregiver and/or family member
available will also be considered eligible
- Absolute neutrophil count (ANC) ≥ 1,500/mcL (obtained within 14 days prior to Step 1
registration)
- Platelets ≥ 75,000/mcL (obtained within 14 days prior to Step 1 registration)
- Hemoglobin (Hgb) ≥ 8.0 g/dL (obtained within 14 days prior to Step 1 registration)
- Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) (obtained within
14 days prior to Step 1 registration)
- Aspartate aminotransferase (AST) (serum glutamic-oxaloacetic transaminase
[SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase
[SGPT]) ≤ 3.0 × institutional ULN (obtained within 14 days prior to Step 1
registration)
- Creatinine clearance (CrCL) ≥ 45 mL/min (estimated using Cockcroft-Gault method with
actual body weight or measured) (obtained within 14 days prior to Step 1
registration)
- Human immunodeficiency virus (HIV)-infected patients on effective antiretroviral
therapy with undetectable viral load within 6 months of Step 1 registration are
eligible for this trial
- For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV
viral load must be undetectable on suppressive therapy, if indicated
- Patients with a history of hepatitis C virus (HCV) infection must have been treated
and cured. For patients with HCV infection who are currently on treatment, they are
eligible if they have undetectable HCV viral
- Patients with a prior or concurrent malignancy whose natural history or treatment
does not have the potential to interfere with the safety or efficacy assessment of
the investigational regimen are eligible for this trial
- Patient must be English or Spanish speaking to be eligible for the QOL component of
the study
- NOTE: Sites cannot translate the associated QOL forms
- Patient must not have symptomatic central nervous system disease (CNS) metastases.
Patients with a clinical history of CNS metastases or cord compression are eligible
if they have been definitively treated and are clinically stable for at least 14
days prior to Step 1 registration and off all steroids for at least 24 hours prior
to Step 1 registration. Patients with asymptomatic CNS metastases are eligible
- Patient must not have had any prior cytotoxic chemotherapy regimen for metastatic
disease. Chemotherapy given in the setting of adjuvant therapy or locally advanced
disease is allowed as long as treatment was completed, and they have fully recovered
from treatment related adverse events prior to Step 1 registration
- Patient must not have had any prior immunotherapy for metastatic disease.
Immunotherapy given in the setting of adjuvant therapy or locally advanced disease
is allowed as long as treatment was completed greater than 6 months prior to Step 1
registration
- Patient must not have a history of uncontrolled autoimmune conditions with the
following exceptions, which are allowed: alopecia, vitiligo, rheumatoid arthritis,
psoriasis/psoriatic arthritis, Hashimoto's thyroiditis, lupus, inflammatory bowel
disease
- Patient must not be on immunosuppressive medication, including steroids (if doses
exceed the equivalent of prednisone 10 mg daily). Short courses of steroids which
are discontinued prior to randomization are acceptable. Patients on inhaled,
intranasal and/or topical steroids are eligible
- Investigator must declare their intended chemotherapy regimen should their patient
be randomized to Arm B (doublet vs singlet)
- STEP 2 RANDOMIZATION
- Patient must have completed the baseline Geriatric Assessment (GA) after Step 1
registration and prior to Step 2 randomization
Gender:
All
Minimum age:
70 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Highlands Oncology Group - Fayetteville
Address:
City:
Fayetteville
Zip:
72703
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
479-872-8100
Email:
research@hogonc.com
Investigator:
Last name:
Joseph T. Beck
Email:
Principal Investigator
Facility:
Name:
Highlands Oncology Group - Rogers
Address:
City:
Rogers
Zip:
72758
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
479-872-8130
Email:
research@hogonc.com
Investigator:
Last name:
Joseph T. Beck
Email:
Principal Investigator
Facility:
Name:
Highlands Oncology Group
Address:
City:
Springdale
Zip:
72762
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
479-872-8130
Email:
research@hogonc.com
Investigator:
Last name:
Joseph T. Beck
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente Dublin
Address:
City:
Dublin
Zip:
94568
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Fremont
Address:
City:
Fremont
Zip:
94538
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Fresno
Address:
City:
Fresno
Zip:
93720
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Modesto
Address:
City:
Modesto
Zip:
95356
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Oakland
Address:
City:
Oakland
Zip:
94611
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Roseville
Address:
City:
Roseville
Zip:
95661
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente Downtown Commons
Address:
City:
Sacramento
Zip:
95814
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-South Sacramento
Address:
City:
Sacramento
Zip:
95823
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-San Francisco
Address:
City:
San Francisco
Zip:
94115
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Santa Teresa-San Jose
Address:
City:
San Jose
Zip:
95119
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente San Leandro
Address:
City:
San Leandro
Zip:
94577
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser San Rafael-Gallinas
Address:
City:
San Rafael
Zip:
94903
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente Medical Center - Santa Clara
Address:
City:
Santa Clara
Zip:
95051
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Santa Rosa
Address:
City:
Santa Rosa
Zip:
95403
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-South San Francisco
Address:
City:
South San Francisco
Zip:
94080
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Vallejo
Address:
City:
Vallejo
Zip:
94589
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Walnut Creek
Address:
City:
Walnut Creek
Zip:
94596
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
UM Sylvester Comprehensive Cancer Center at Aventura
Address:
City:
Aventura
Zip:
33180
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
954-461-2180
Investigator:
Last name:
Chukwuemeka (Emeka) V. Ikpeazu
Email:
Principal Investigator
Facility:
Name:
UM Sylvester Comprehensive Cancer Center at Coral Gables
Address:
City:
Coral Gables
Zip:
33146
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
305-243-2647
Investigator:
Last name:
Chukwuemeka (Emeka) V. Ikpeazu
Email:
Principal Investigator
Facility:
Name:
UM Sylvester Comprehensive Cancer Center at Deerfield Beach
Address:
City:
Deerfield Beach
Zip:
33442
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
305-243-2647
Investigator:
Last name:
Chukwuemeka (Emeka) V. Ikpeazu
Email:
Principal Investigator
Facility:
Name:
University of Miami Miller School of Medicine-Sylvester Cancer Center
Address:
City:
Miami
Zip:
33136
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
305-243-2647
Investigator:
Last name:
Chukwuemeka (Emeka) V. Ikpeazu
Email:
Principal Investigator
Facility:
Name:
UM Sylvester Comprehensive Cancer Center at Kendall
Address:
City:
Miami
Zip:
33176
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
305-243-2647
Investigator:
Last name:
Chukwuemeka (Emeka) V. Ikpeazu
Email:
Principal Investigator
Facility:
Name:
UM Sylvester Comprehensive Cancer Center at Plantation
Address:
City:
Plantation
Zip:
33324
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
305-243-2647
Investigator:
Last name:
Chukwuemeka (Emeka) V. Ikpeazu
Email:
Principal Investigator
Facility:
Name:
Moffitt Cancer Center - McKinley Campus
Address:
City:
Tampa
Zip:
33612
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-679-0775
Email:
ClinicalTrials@moffitt.org
Investigator:
Last name:
Mohammed Al-Jumayli
Email:
Principal Investigator
Facility:
Name:
Moffitt Cancer Center
Address:
City:
Tampa
Zip:
33612
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-679-0775
Email:
ClinicalTrials@moffitt.org
Investigator:
Last name:
Mohammed Al-Jumayli
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente Moanalua Medical Center
Address:
City:
Honolulu
Zip:
96819
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
808-432-5195
Email:
shelley.a.clark@kp.org
Investigator:
Last name:
Jennifer M. Suga
Email:
Principal Investigator
Facility:
Name:
Saint Alphonsus Cancer Care Center-Boise
Address:
City:
Boise
Zip:
83706
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-3671
Email:
stephanie.couch@stjoeshealth.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Saint Alphonsus Cancer Care Center-Caldwell
Address:
City:
Caldwell
Zip:
83605
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-3671
Email:
stephanie.couch@stjoeshealth.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Kootenai Health - Coeur d'Alene
Address:
City:
Coeur d'Alene
Zip:
83814
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Saint Alphonsus Cancer Care Center-Nampa
Address:
City:
Nampa
Zip:
83687
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Kootenai Clinic Cancer Services - Post Falls
Address:
City:
Post Falls
Zip:
83854
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Kootenai Clinic Cancer Services - Sandpoint
Address:
City:
Sandpoint
Zip:
83864
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Rush - Copley Medical Center
Address:
City:
Aurora
Zip:
60504
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-978-6212
Email:
Cancer.Research@rushcopley.com
Investigator:
Last name:
Tanmay Sahai
Email:
Principal Investigator
Facility:
Name:
University of Illinois
Address:
City:
Chicago
Zip:
60612
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
312-355-3046
Investigator:
Last name:
Frank Weinberg
Email:
Principal Investigator
Facility:
Name:
Carle at The Riverfront
Address:
City:
Danville
Zip:
61832
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-446-5532
Email:
Research@Carle.com
Investigator:
Last name:
Tanmay Sahai
Email:
Principal Investigator
Facility:
Name:
Cancer Care Specialists of Illinois - Decatur
Address:
City:
Decatur
Zip:
62526
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-876-4762
Email:
morganthaler.jodi@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Decatur Memorial Hospital
Address:
City:
Decatur
Zip:
62526
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-876-4762
Email:
morganthaler.jodi@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Carle Physician Group-Effingham
Address:
City:
Effingham
Zip:
62401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-446-5532
Email:
Research@carle.com
Investigator:
Last name:
Tanmay Sahai
Email:
Principal Investigator
Facility:
Name:
Crossroads Cancer Center
Address:
City:
Effingham
Zip:
62401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-876-4762
Email:
morganthaler.jodi@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Carle Physician Group-Mattoon/Charleston
Address:
City:
Mattoon
Zip:
61938
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-446-5532
Email:
Research@carle.com
Investigator:
Last name:
Tanmay Sahai
Email:
Principal Investigator
Facility:
Name:
UW Health Carbone Cancer Center Rockford
Address:
City:
Rockford
Zip:
61114
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
779-696-9378
Email:
lkline@uwhealth.org
Investigator:
Last name:
Fahrettin Covut
Email:
Principal Investigator
Facility:
Name:
Memorial Hospital East
Address:
City:
Shiloh
Zip:
62269
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-747-9912
Email:
dschwab@wustl.edu
Investigator:
Last name:
Maria Q. Baggstrom
Email:
Principal Investigator
Facility:
Name:
Southern Illinois University School of Medicine
Address:
City:
Springfield
Zip:
62702
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-545-7929
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Springfield Clinic
Address:
City:
Springfield
Zip:
62702
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-444-7541
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Springfield Memorial Hospital
Address:
City:
Springfield
Zip:
62781
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-528-7541
Email:
pallante.beth@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Carle Cancer Center
Address:
City:
Urbana
Zip:
61801
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-446-5532
Email:
Research@carle.com
Investigator:
Last name:
Tanmay Sahai
Email:
Principal Investigator
Facility:
Name:
Northwest Cancer Center - Main Campus
Address:
City:
Crown Point
Zip:
46307
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
219-310-2550
Investigator:
Last name:
Tanmay Sahai
Email:
Principal Investigator
Facility:
Name:
Northwest Oncology LLC
Address:
City:
Dyer
Zip:
46311
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
219-924-8178
Investigator:
Last name:
Tanmay Sahai
Email:
Principal Investigator
Facility:
Name:
Northwest Cancer Center - Hobart
Address:
City:
Hobart
Zip:
46342
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
219-947-1795
Investigator:
Last name:
Tanmay Sahai
Email:
Principal Investigator
Facility:
Name:
Saint Mary Medical Center
Address:
City:
Hobart
Zip:
46342
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
219-836-6875
Email:
CancerResearch@COMHS.org
Investigator:
Last name:
Tanmay Sahai
Email:
Principal Investigator
Facility:
Name:
Saint Catherine Hospital
Address:
City:
Indianapolis
Zip:
46312
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
ecog.rss@jimmy.harvard.edu
Investigator:
Last name:
Tanmay Sahai
Email:
Principal Investigator
Facility:
Name:
The Community Hospital
Address:
City:
Munster
Zip:
46321
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
219-836-3349
Investigator:
Last name:
Tanmay Sahai
Email:
Principal Investigator
Facility:
Name:
Women's Diagnostic Center - Munster
Address:
City:
Munster
Zip:
46321
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
219-934-8869
Email:
mnicholson@comhs.org
Investigator:
Last name:
Tanmay Sahai
Email:
Principal Investigator
Facility:
Name:
Northwest Cancer Center - Valparaiso
Address:
City:
Valparaiso
Zip:
46383
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
219-836-6875
Email:
CancerResearch@COMHS.org
Investigator:
Last name:
Tanmay Sahai
Email:
Principal Investigator
Facility:
Name:
Mission Cancer and Blood - Ankeny
Address:
City:
Ankeny
Zip:
50023
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-282-2921
Investigator:
Last name:
Seema Harichand-Herdt
Email:
Principal Investigator
Facility:
Name:
Mercy Hospital
Address:
City:
Cedar Rapids
Zip:
52403
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
319-365-4673
Investigator:
Last name:
Deborah W. Wilbur
Email:
Principal Investigator
Facility:
Name:
Oncology Associates at Mercy Medical Center
Address:
City:
Cedar Rapids
Zip:
52403
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
319-363-2690
Investigator:
Last name:
Deborah W. Wilbur
Email:
Principal Investigator
Facility:
Name:
Mercy Cancer Center-West Lakes
Address:
City:
Clive
Zip:
50325
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-358-6613
Email:
cancerresearch@mercydesmoines.org
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
Mission Cancer and Blood - West Des Moines
Address:
City:
Clive
Zip:
50325
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-241-3305
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
Mission Cancer and Blood - Des Moines
Address:
City:
Des Moines
Zip:
50309
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-241-3305
Investigator:
Last name:
Seema Harichand-Herdt
Email:
Principal Investigator
Facility:
Name:
Mercy Medical Center - Des Moines
Address:
City:
Des Moines
Zip:
50314
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-358-6613
Email:
cancerresearch@mercydesmoines.org
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
Mission Cancer and Blood - Laurel
Address:
City:
Des Moines
Zip:
50314
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-241-3305
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
University of Kansas Clinical Research Center
Address:
City:
Fairway
Zip:
66205
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Chao H. Huang
Email:
Principal Investigator
Facility:
Name:
University of Kansas Cancer Center
Address:
City:
Kansas City
Zip:
66160
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Chao H. Huang
Email:
Principal Investigator
Facility:
Name:
Lawrence Memorial Hospital
Address:
City:
Lawrence
Zip:
66044
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
785-505-2800
Email:
Stephanie.Norris@LMH.ORG
Investigator:
Last name:
Chao H. Huang
Email:
Principal Investigator
Facility:
Name:
Olathe Health Cancer Center
Address:
City:
Olathe
Zip:
66061
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-355-3943
Email:
atheCCResearch@kumc.edu
Investigator:
Last name:
Chao H. Huang
Email:
Principal Investigator
Facility:
Name:
University of Kansas Cancer Center-Overland Park
Address:
City:
Overland Park
Zip:
66210
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Chao H. Huang
Email:
Principal Investigator
Facility:
Name:
University of Kansas Hospital-Indian Creek Campus
Address:
City:
Overland Park
Zip:
66211
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Chao H. Huang
Email:
Principal Investigator
Facility:
Name:
Salina Regional Health Center
Address:
City:
Salina
Zip:
67401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
785-452-7038
Email:
mleepers@srhc.com
Investigator:
Last name:
Chao H. Huang
Email:
Principal Investigator
Facility:
Name:
University of Kansas Health System Saint Francis Campus
Address:
City:
Topeka
Zip:
66606
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
785-295-8000
Investigator:
Last name:
Chao H. Huang
Email:
Principal Investigator
Facility:
Name:
University of Kansas Hospital-Westwood Cancer Center
Address:
City:
Westwood
Zip:
66205
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Chao H. Huang
Email:
Principal Investigator
Facility:
Name:
The James Graham Brown Cancer Center at University of Louisville
Address:
City:
Louisville
Zip:
40202
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
502-562-3429
Investigator:
Last name:
Jason A. Chesney
Email:
Principal Investigator
Facility:
Name:
UofL Health Medical Center Northeast
Address:
City:
Louisville
Zip:
40245
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
502-852-2755
Email:
ctoinfo@louisville.edu
Investigator:
Last name:
Jason A. Chesney
Email:
Principal Investigator
Facility:
Name:
Lafayette Family Cancer Center-EMMC
Address:
City:
Brewer
Zip:
04412
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-987-3005
Investigator:
Last name:
Sarah J. Sinclair
Email:
Principal Investigator
Facility:
Name:
Sinai Hospital of Baltimore
Address:
City:
Baltimore
Zip:
21215
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
410-601-6120
Email:
pridgely@lifebridgehealth.org
Investigator:
Last name:
Vishal Jindal
Email:
Principal Investigator
Facility:
Name:
William E Kahlert Regional Cancer Center/Sinai Hospital
Address:
City:
Westminster
Zip:
21157
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
410-871-6400
Investigator:
Last name:
Vishal Jindal
Email:
Principal Investigator
Facility:
Name:
Tufts Medical Center
Address:
City:
Boston
Zip:
02111
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
617-636-5000
Email:
ContactUsCancerCenter@TuftsMedicalCenter.org
Investigator:
Last name:
Lori H. Pai
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Brighton
Address:
City:
Brighton
Zip:
48114
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Canton
Address:
City:
Canton
Zip:
48188
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
Address:
City:
Chelsea
Zip:
48118
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Genesee Cancer and Blood Disease Treatment Center
Address:
City:
Flint
Zip:
48503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
810-762-8038
Email:
wstrong@ghci.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Genesee Hematology Oncology PC
Address:
City:
Flint
Zip:
48503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
810-762-8038
Email:
wstrong@ghci.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Genesys Hurley Cancer Institute
Address:
City:
Flint
Zip:
48503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
810-762-8038
Email:
wstrong@ghci.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Hurley Medical Center
Address:
City:
Flint
Zip:
48503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
810-762-8038
Email:
wstrong@ghci.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
University of Michigan Health - Sparrow Lansing
Address:
City:
Lansing
Zip:
48912
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
517-364-3712
Email:
harsha.trivedi@umhsparrow.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health Saint Mary Mercy Livonia Hospital
Address:
City:
Livonia
Zip:
48154
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Michigan Healthcare Professionals Pontiac
Address:
City:
Pontiac
Zip:
48341
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
248-858-6215
Email:
Emily.Crofts@trinity-health.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health Saint Joseph Mercy Oakland Hospital
Address:
City:
Pontiac
Zip:
48341
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
MyMichigan Medical Center Saginaw
Address:
City:
Saginaw
Zip:
48601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Oncology Hematology Associates of Saginaw Valley PC
Address:
City:
Saginaw
Zip:
48604
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
989-907-8411
Email:
lori.srebinski@ascension.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
MyMichigan Medical Center Tawas
Address:
City:
Tawas City
Zip:
48764
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Saint Mary's Oncology/Hematology Associates of West Branch
Address:
City:
West Branch
Zip:
48661
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
989-907-8411
Email:
lori.srebinski@ascension.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
Address:
City:
Ypsilanti
Zip:
48197
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Christopher M. Reynolds
Email:
Principal Investigator
Facility:
Name:
Sanford Joe Lueken Cancer Center
Address:
City:
Bemidji
Zip:
56601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-333-5000
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Mercy Hospital
Address:
City:
Coon Rapids
Zip:
55433
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
952-993-1517
Email:
mmcorc@healthpartners.com
Investigator:
Last name:
David M. King
Email:
Principal Investigator
Facility:
Name:
Essentia Health - Deer River Clinic
Address:
City:
Deer River
Zip:
56636
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-786-3308
Email:
CancerTrials@EssentiaHealth.org
Investigator:
Last name:
Bret E. Friday
Email:
Principal Investigator
Facility:
Name:
Essentia Health Cancer Center
Address:
City:
Duluth
Zip:
55805
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-786-3308
Email:
CancerTrials@EssentiaHealth.org
Investigator:
Last name:
Bret E. Friday
Email:
Principal Investigator
Facility:
Name:
Fairview Southdale Hospital
Address:
City:
Edina
Zip:
55435
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
952-993-1517
Email:
mmcorc@healthpartners.com
Investigator:
Last name:
David M. King
Email:
Principal Investigator
Facility:
Name:
Essentia Health Hibbing Clinic
Address:
City:
Hibbing
Zip:
55746
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-786-3308
Investigator:
Last name:
Bret E. Friday
Email:
Principal Investigator
Facility:
Name:
Mayo Clinic Health Systems-Mankato
Address:
City:
Mankato
Zip:
56001
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
855-776-0015
Investigator:
Last name:
Eyad S. AlHattab
Email:
Principal Investigator
Facility:
Name:
Abbott-Northwestern Hospital
Address:
City:
Minneapolis
Zip:
55407
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
952-993-1517
Email:
mmcorc@healthpartners.com
Investigator:
Last name:
David M. King
Email:
Principal Investigator
Facility:
Name:
Park Nicollet Clinic - Saint Louis Park
Address:
City:
Saint Louis Park
Zip:
55416
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
952-993-1517
Email:
mmcorc@healthpartners.com
Investigator:
Last name:
David M. King
Email:
Principal Investigator
Facility:
Name:
Regions Hospital
Address:
City:
Saint Paul
Zip:
55101
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
952-993-1517
Email:
mmcorc@healthpartners.com
Investigator:
Last name:
David M. King
Email:
Principal Investigator
Facility:
Name:
United Hospital
Address:
City:
Saint Paul
Zip:
55102
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
952-993-1517
Email:
mmcorc@healthpartners.com
Investigator:
Last name:
David M. King
Email:
Principal Investigator
Facility:
Name:
Essentia Health Sandstone
Address:
City:
Sandstone
Zip:
55072
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-786-3308
Email:
CancerTrials@EssentiaHealth.org
Investigator:
Last name:
Bret E. Friday
Email:
Principal Investigator
Facility:
Name:
Essentia Health Virginia Clinic
Address:
City:
Virginia
Zip:
55792
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-786-3308
Email:
CancerTrials@EssentiaHealth.org
Investigator:
Last name:
Bret E. Friday
Email:
Principal Investigator
Facility:
Name:
Saint Francis Medical Center
Address:
City:
Cape Girardeau
Zip:
63703
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
573-334-2230
Email:
sfmc@sfmc.net
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at West County Hospital
Address:
City:
Creve Coeur
Zip:
63141
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Maria Q. Baggstrom
Email:
Principal Investigator
Facility:
Name:
University Health Truman Medical Center
Address:
City:
Kansas City
Zip:
64108
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
816-404-4375
Investigator:
Last name:
Chao H. Huang
Email:
Principal Investigator
Facility:
Name:
Kansas City Veterans Affairs Medical Center
Address:
City:
Kansas City
Zip:
64128
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-525-1483
Investigator:
Last name:
Chao H. Huang
Email:
Principal Investigator
Facility:
Name:
University of Kansas Cancer Center - North
Address:
City:
Kansas City
Zip:
64154
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Chao H. Huang
Email:
Principal Investigator
Facility:
Name:
University of Kansas Cancer Center - Lee's Summit
Address:
City:
Lee's Summit
Zip:
64064
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Chao H. Huang
Email:
Principal Investigator
Facility:
Name:
Lake Regional Hospital
Address:
City:
Osage Beach
Zip:
65065
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
573-302-2768
Email:
clinicaltrials@lakeregional.com
Investigator:
Last name:
Jay W. Carlson
Email:
Principal Investigator
Facility:
Name:
Washington University School of Medicine
Address:
City:
Saint Louis
Zip:
63110
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Maria Q. Baggstrom
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center-South County
Address:
City:
Saint Louis
Zip:
63129
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Maria Q. Baggstrom
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at Christian Hospital
Address:
City:
Saint Louis
Zip:
63136
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Maria Q. Baggstrom
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at Saint Peters Hospital
Address:
City:
Saint Peters
Zip:
63376
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Maria Q. Baggstrom
Email:
Principal Investigator
Facility:
Name:
Community Hospital of Anaconda
Address:
City:
Anaconda
Zip:
59711
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Billings Clinic Cancer Center
Address:
City:
Billings
Zip:
59101
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-996-2663
Email:
research@billingsclinic.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Bozeman Health Deaconess Hospital
Address:
City:
Bozeman
Zip:
59715
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Benefis Sletten Cancer Institute
Address:
City:
Great Falls
Zip:
59405
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Logan Health Medical Center
Address:
City:
Kalispell
Zip:
59901
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Community Medical Center
Address:
City:
Missoula
Zip:
59804
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
Address:
City:
Lebanon
Zip:
03756
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-639-6918
Email:
cancer.research.nurse@dartmouth.edu
Investigator:
Last name:
Alexander D. Fuld
Email:
Principal Investigator
Facility:
Name:
Inspira Medical Center Mullica Hill
Address:
City:
Mullica Hill
Zip:
08062
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
856-508-3500
Email:
DeNigrisJ@ihn.org
Investigator:
Last name:
Erev E. Tubb
Email:
Principal Investigator
Facility:
Name:
Penn Medicine Princeton Health
Address:
City:
Plainsboro
Zip:
08536
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
855-216-0098
Email:
PennCancerTrials@careboxhealth.com
Investigator:
Last name:
Ramy Sedhom
Email:
Principal Investigator
Facility:
Name:
Sidney Kimmel Cancer Center Washington Township
Address:
City:
Sewell
Zip:
08080
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
215-600-9151
Email:
ONCTrialNow@jefferson.edu
Investigator:
Last name:
Ida Micaily
Email:
Principal Investigator
Facility:
Name:
Montefiore Medical Center-Einstein Campus
Address:
City:
Bronx
Zip:
10461
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
718-379-6866
Email:
eskwak@montefiore.org
Investigator:
Last name:
Balazs Halmos
Email:
Principal Investigator
Facility:
Name:
Montefiore Medical Center - Moses Campus
Address:
City:
Bronx
Zip:
10467
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
718-379-6866
Email:
eskwak@montefiore.org
Investigator:
Last name:
Balazs Halmos
Email:
Principal Investigator
Facility:
Name:
Upstate Cancer Center at Oswego
Address:
City:
Oswego
Zip:
13126
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
315-464-8230
Email:
McDowelE@upstate.edu
Investigator:
Last name:
Stephen L. Graziano
Email:
Principal Investigator
Facility:
Name:
University of Rochester
Address:
City:
Rochester
Zip:
14642
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
585-275-5830
Investigator:
Last name:
Paul M. Barr
Email:
Principal Investigator
Facility:
Name:
Stony Brook University Medical Center
Address:
City:
Stony Brook
Zip:
11794
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-862-2215
Investigator:
Last name:
Amna Sher
Email:
Principal Investigator
Facility:
Name:
State University of New York Upstate Medical University
Address:
City:
Syracuse
Zip:
13210
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
315-464-5476
Investigator:
Last name:
Stephen L. Graziano
Email:
Principal Investigator
Facility:
Name:
SUNY Upstate Medical Center-Community Campus
Address:
City:
Syracuse
Zip:
13215
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
315-464-5476
Investigator:
Last name:
Stephen L. Graziano
Email:
Principal Investigator
Facility:
Name:
Upstate Cancer Center at Verona
Address:
City:
Verona
Zip:
13478
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
315-464-8230
Email:
McDowelE@upstate.edu
Investigator:
Last name:
Stephen L. Graziano
Email:
Principal Investigator
Facility:
Name:
Wilmot Cancer Institute at Webster
Address:
City:
Webster
Zip:
14580
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
WCICTOresearch@urmc.rochester.edu
Investigator:
Last name:
Paul M. Barr
Email:
Principal Investigator
Facility:
Name:
Durham VA Medical Center
Address:
City:
Durham
Zip:
27705
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
919-286-0411
Email:
VHADURcancertrials@va.gov
Investigator:
Last name:
Michael J. Kelley
Email:
Principal Investigator
Facility:
Name:
Sanford Bismarck Medical Center
Address:
City:
Bismarck
Zip:
58501
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
701-323-5760
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Sanford Broadway Medical Center
Address:
City:
Fargo
Zip:
58122
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
701-323-5760
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Sanford Roger Maris Cancer Center
Address:
City:
Fargo
Zip:
58122
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
701-234-6161
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Strecker Cancer Center-Belpre
Address:
City:
Belpre
Zip:
45714
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
614-488-2745
Email:
Jeffh@columbusccop.org
Investigator:
Last name:
William A. Wilson
Email:
Principal Investigator
Facility:
Name:
Aultman Health Foundation
Address:
City:
Canton
Zip:
44710
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
330-363-7274
Email:
ClinicalReserachDept@aultman.com
Investigator:
Last name:
Raza A. Khan
Email:
Principal Investigator
Facility:
Name:
Miami Valley Hospital South
Address:
City:
Centerville
Zip:
45459
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-528-2900
Email:
clinical.trials@daytonncorp.org
Investigator:
Last name:
Tarek M. Sabagh
Email:
Principal Investigator
Facility:
Name:
Adena Regional Medical Center
Address:
City:
Chillicothe
Zip:
45601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-779-7585
Email:
Jeffh@columbusccop.org
Investigator:
Last name:
William A. Wilson
Email:
Principal Investigator
Facility:
Name:
MetroHealth Medical Center
Address:
City:
Cleveland
Zip:
44109
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
216-778-7559
Email:
ababal@metrohealth.org
Investigator:
Last name:
Peter Xie
Email:
Principal Investigator
Facility:
Name:
Ohio State University Comprehensive Cancer Center
Address:
City:
Columbus
Zip:
43210
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-293-5066
Email:
Jamesline@osumc.edu
Investigator:
Last name:
Carolyn J. Presley
Email:
Principal Investigator
Facility:
Name:
The Mark H Zangmeister Center
Address:
City:
Columbus
Zip:
43219
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
614-488-2745
Email:
Jeffh@columbusccop.org
Investigator:
Last name:
William A. Wilson
Email:
Principal Investigator
Facility:
Name:
Miami Valley Hospital
Address:
City:
Dayton
Zip:
45409
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-528-2900
Email:
clinical.trials@daytonncorp.org
Investigator:
Last name:
Tarek M. Sabagh
Email:
Principal Investigator
Facility:
Name:
Premier Blood and Cancer Center
Address:
City:
Dayton
Zip:
45409
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-276-8320
Investigator:
Last name:
Tarek M. Sabagh
Email:
Principal Investigator
Facility:
Name:
Miami Valley Hospital North
Address:
City:
Dayton
Zip:
45415
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-528-2900
Email:
clinical.trials@daytonncorp.org
Investigator:
Last name:
Tarek M. Sabagh
Email:
Principal Investigator
Facility:
Name:
Atrium Medical Center-Middletown Regional Hospital
Address:
City:
Franklin
Zip:
45005-1066
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-528-2900
Email:
clinical.trials@daytonncorp.org
Investigator:
Last name:
Tarek M. Sabagh
Email:
Principal Investigator
Facility:
Name:
Miami Valley Cancer Care and Infusion
Address:
City:
Greenville
Zip:
45331
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-569-7515
Investigator:
Last name:
Tarek M. Sabagh
Email:
Principal Investigator
Facility:
Name:
Mount Carmel Grove City Hospital
Address:
City:
Grove City
Zip:
43123
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
614-488-2745
Email:
Jeffh@columbusccop.org
Investigator:
Last name:
William A. Wilson
Email:
Principal Investigator
Facility:
Name:
Memorial Hospital
Address:
City:
Marysville
Zip:
43040
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
614-488-2745
Email:
Jeffh@columbusccop.org
Investigator:
Last name:
William A. Wilson
Email:
Principal Investigator
Facility:
Name:
Knox Community Hospital
Address:
City:
Mount Vernon
Zip:
43050
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
614-488-2745
Email:
Jeffh@columbusccop.org
Investigator:
Last name:
William A. Wilson
Email:
Principal Investigator
Facility:
Name:
Licking Memorial Hospital
Address:
City:
Newark
Zip:
43055
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
614-488-2745
Email:
Jeffh@columbusccop.org
Investigator:
Last name:
William A. Wilson
Email:
Principal Investigator
Facility:
Name:
Mercy Health Perrysburg Cancer Center
Address:
City:
Perrysburg
Zip:
43551
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
614-488-2745
Email:
Jeffh@columbusccop.org
Investigator:
Last name:
William A. Wilson
Email:
Principal Investigator
Facility:
Name:
Springfield Regional Cancer Center
Address:
City:
Springfield
Zip:
45504
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
614-488-2745
Email:
Jeffh@columbusccop.org
Investigator:
Last name:
William A. Wilson
Email:
Principal Investigator
Facility:
Name:
Mercy Health - Saint Anne Hospital
Address:
City:
Toledo
Zip:
43623
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
614-488-2745
Email:
Jeffh@columbusccop.org
Investigator:
Last name:
William A. Wilson
Email:
Principal Investigator
Facility:
Name:
Upper Valley Medical Center
Address:
City:
Troy
Zip:
45373
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
937-528-2900
Email:
clinical.trials@daytonncorp.org
Investigator:
Last name:
Tarek M. Sabagh
Email:
Principal Investigator
Facility:
Name:
Genesis Healthcare System Cancer Care Center
Address:
City:
Zanesville
Zip:
43701
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
614-488-2745
Email:
Jeffh@columbusccop.org
Investigator:
Last name:
William A. Wilson
Email:
Principal Investigator
Facility:
Name:
Mercy Hospital Oklahoma City
Address:
City:
Oklahoma City
Zip:
73120
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
405-752-3402
Investigator:
Last name:
Jay W. Carlson
Email:
Principal Investigator
Facility:
Name:
Saint Alphonsus Cancer Care Center-Ontario
Address:
City:
Ontario
Zip:
97914
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Bryn Mawr Hospital
Address:
City:
Bryn Mawr
Zip:
19010
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
484-476-2649
Email:
turzoe@mlhs.org
Investigator:
Last name:
Deric C. Savior
Email:
Principal Investigator
Facility:
Name:
Riddle Memorial Hospital
Address:
City:
Media
Zip:
19063
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
484-476-2649
Email:
turzoe@mlhs.org
Investigator:
Last name:
Deric C. Savior
Email:
Principal Investigator
Facility:
Name:
Paoli Memorial Hospital
Address:
City:
Paoli
Zip:
19301
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
484-476-2649
Email:
turzoe@mlhs.org
Investigator:
Last name:
Deric C. Savior
Email:
Principal Investigator
Facility:
Name:
ECOG-ACRIN Cancer Research Group
Address:
City:
Philadelphia
Zip:
19103
Country:
United States
Status:
Recruiting
Contact:
Last name:
Megan A. Baumgart
Email:
megan_baumgart@urmc.rochester.edu
Investigator:
Last name:
Megan A. Baumgart
Email:
Principal Investigator
Facility:
Name:
Thomas Jefferson University Hospital
Address:
City:
Philadelphia
Zip:
19107
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
215-600-9151
Email:
ONCTrialNow@jefferson.edu
Investigator:
Last name:
Ida Micaily
Email:
Principal Investigator
Facility:
Name:
Jefferson Torresdale Hospital
Address:
City:
Philadelphia
Zip:
19114
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
215-600-9151
Email:
ONCTrialNow@jefferson.edu
Investigator:
Last name:
Ida Micaily
Email:
Principal Investigator
Facility:
Name:
Phoenixville Hospital
Address:
City:
Phoenixville
Zip:
19460
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
610-983-1800
Investigator:
Last name:
Rashmika R. Potdar
Email:
Principal Investigator
Facility:
Name:
Guthrie Medical Group PC-Robert Packer Hospital
Address:
City:
Sayre
Zip:
18840
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-836-0388
Investigator:
Last name:
Joyson Poulose
Email:
Principal Investigator
Facility:
Name:
Reading Hospital
Address:
City:
West Reading
Zip:
19611
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
610-988-9323
Investigator:
Last name:
Terrence P. Cescon
Email:
Principal Investigator
Facility:
Name:
Asplundh Cancer Pavilion
Address:
City:
Willow Grove
Zip:
19090
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
215-600-9151
Email:
ONCTrialNow@jefferson.edu
Investigator:
Last name:
Ida Micaily
Email:
Principal Investigator
Facility:
Name:
Lankenau Medical Center
Address:
City:
Wynnewood
Zip:
19096
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
484-476-2649
Email:
turzoe@mlhs.org
Investigator:
Last name:
Deric C. Savior
Email:
Principal Investigator
Facility:
Name:
Medical University of South Carolina
Address:
City:
Charleston
Zip:
29425
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
843-792-9321
Email:
hcc-clinical-trials@musc.edu
Investigator:
Last name:
Christopher A. Rangel
Email:
Principal Investigator
Facility:
Name:
Rapid City Regional Hospital
Address:
City:
Rapid City
Zip:
57701
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
605-755-2370
Email:
research@monument.health
Investigator:
Last name:
Abdel-Ghani Azzouqa
Email:
Principal Investigator
Facility:
Name:
Sanford Cancer Center Oncology Clinic
Address:
City:
Sioux Falls
Zip:
57104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
605-312-3320
Email:
OncologyClinicTrialsSF@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Sanford USD Medical Center - Sioux Falls
Address:
City:
Sioux Falls
Zip:
57117-5134
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
605-312-3320
Email:
OncologyClinicalTrialsSF@SanfordHealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Parkland Memorial Hospital
Address:
City:
Dallas
Zip:
75235
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
214-590-5582
Email:
canceranswerline@UTSouthwestern.edu
Investigator:
Last name:
Cynthia Wei
Email:
Principal Investigator
Facility:
Name:
UT Southwestern Simmons Cancer Center - RedBird
Address:
City:
Dallas
Zip:
75237
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
214-648-7097
Email:
canceranswerline@utsouthwestern.edu
Investigator:
Last name:
Cynthia Wei
Email:
Principal Investigator
Facility:
Name:
UT Southwestern/Simmons Cancer Center-Dallas
Address:
City:
Dallas
Zip:
75390
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
214-648-7097
Email:
canceranswerline@UTSouthwestern.edu
Investigator:
Last name:
Cynthia Wei
Email:
Principal Investigator
Facility:
Name:
UT Southwestern/Simmons Cancer Center-Fort Worth
Address:
City:
Fort Worth
Zip:
76104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
214-648-7097
Email:
canceranswerline@UTSouthwestern.edu
Investigator:
Last name:
Cynthia Wei
Email:
Principal Investigator
Facility:
Name:
UT Southwestern Clinical Center at Richardson/Plano
Address:
City:
Richardson
Zip:
75080
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
972-669-7044
Email:
Suzanne.cole@utsouthwestern.edu
Investigator:
Last name:
Cynthia Wei
Email:
Principal Investigator
Facility:
Name:
Dartmouth Cancer Center - North
Address:
City:
Saint Johnsbury
Zip:
05819
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-639-6918
Email:
cancer.research.nurse@hitchcock.org
Investigator:
Last name:
Alexander D. Fuld
Email:
Principal Investigator
Facility:
Name:
University of Virginia Cancer Center
Address:
City:
Charlottesville
Zip:
22908
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
434-243-6303
Email:
uvacancertrials@hscmail.mcc.virginia.edu
Investigator:
Last name:
Ryan D. Gentzler
Email:
Principal Investigator
Facility:
Name:
VCU Massey Cancer Center at Stony Point
Address:
City:
Richmond
Zip:
23235
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
ctoclinops@vcu.edu
Investigator:
Last name:
Jonathan D. Berkman
Email:
Principal Investigator
Facility:
Name:
Virginia Commonwealth University/Massey Cancer Center
Address:
City:
Richmond
Zip:
23298
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
CTOclinops@vcu.edu
Investigator:
Last name:
Jonathan D. Berkman
Email:
Principal Investigator
Facility:
Name:
Langlade Hospital and Cancer Center
Address:
City:
Antigo
Zip:
54409
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
715-623-9869
Email:
Juli.Alford@aspirus.org
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Facility:
Name:
ThedaCare Regional Cancer Center
Address:
City:
Appleton
Zip:
54911
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-364-3604
Email:
ResearchDept@thedacare.org
Investigator:
Last name:
Matthias Weiss
Email:
Principal Investigator
Facility:
Name:
Duluth Clinic Ashland
Address:
City:
Ashland
Zip:
54806
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-786-3308
Email:
CancerTrials@EssentiaHealth.org
Investigator:
Last name:
Bret E. Friday
Email:
Principal Investigator
Facility:
Name:
ThedaCare Cancer Care - Berlin
Address:
City:
Berlin
Zip:
54923
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-364-3605
Email:
ResearchDept@thedacare.org
Investigator:
Last name:
Matthias Weiss
Email:
Principal Investigator
Facility:
Name:
Marshfield Medical Center-EC Cancer Center
Address:
City:
Eau Claire
Zip:
54701
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-782-8581
Email:
oncology.clinical.trials@marshfieldresearch.org
Investigator:
Last name:
Joseph Edmund
Email:
Principal Investigator
Facility:
Name:
Mayo Clinic Health System-Eau Claire Clinic
Address:
City:
Eau Claire
Zip:
54701
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
855-776-0015
Investigator:
Last name:
Eyad S. AlHattab
Email:
Principal Investigator
Facility:
Name:
Gundersen Lutheran Medical Center
Address:
City:
La Crosse
Zip:
54601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
608-775-2385
Email:
cancerctr@gundersenhealth.org
Investigator:
Last name:
Kurt Oettel
Email:
Principal Investigator
Facility:
Name:
Aspirus Medford Hospital
Address:
City:
Medford
Zip:
54451
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
715-847-2353
Email:
Beth.Knetter@aspirus.org
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Facility:
Name:
ProHealth D N Greenwald Center
Address:
City:
Mukwonago
Zip:
53149
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
research.institute@phci.org
Investigator:
Last name:
Timothy R. Wassenaar
Email:
Principal Investigator
Facility:
Name:
ThedaCare Regional Medical Center - Neenah
Address:
City:
Neenah
Zip:
54956
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-364-3605
Email:
ResearchDept@thedacare.org
Investigator:
Last name:
Matthias Weiss
Email:
Principal Investigator
Facility:
Name:
ThedaCare Cancer Care - New London
Address:
City:
New London
Zip:
54961
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-364-3605
Email:
ResearchDept@thedacare.org
Investigator:
Last name:
Matthias Weiss
Email:
Principal Investigator
Facility:
Name:
ProHealth Oconomowoc Memorial Hospital
Address:
City:
Oconomowoc
Zip:
53066
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
262-928-7878
Investigator:
Last name:
Timothy R. Wassenaar
Email:
Principal Investigator
Facility:
Name:
ThedaCare Cancer Care - Oshkosh
Address:
City:
Oshkosh
Zip:
54904
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-364-3605
Email:
ResearchDept@thedacare.org
Investigator:
Last name:
Matthias Weiss
Email:
Principal Investigator
Facility:
Name:
Aspirus Cancer Care - James Beck Cancer Center
Address:
City:
Rhinelander
Zip:
54501
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
715-847-2353
Email:
Beth.Knetter@aspirus.org
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Facility:
Name:
ThedaCare Cancer Care - Shawano
Address:
City:
Shawano
Zip:
54166
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-364-3605
Email:
ResearchDept@thedacare.org
Investigator:
Last name:
Matthias Weiss
Email:
Principal Investigator
Facility:
Name:
Aspirus Cancer Care - Stevens Point
Address:
City:
Stevens Point
Zip:
54481
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
715-847-2353
Email:
Beth.Knetter@aspirus.org
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Facility:
Name:
ProHealth Waukesha Memorial Hospital
Address:
City:
Waukesha
Zip:
53188
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
262-928-7632
Investigator:
Last name:
Timothy R. Wassenaar
Email:
Principal Investigator
Facility:
Name:
UW Cancer Center at ProHealth Care
Address:
City:
Waukesha
Zip:
53188
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
262-928-5539
Email:
Chanda.miller@phci.org
Investigator:
Last name:
Timothy R. Wassenaar
Email:
Principal Investigator
Facility:
Name:
ThedaCare Cancer Care - Waupaca
Address:
City:
Waupaca
Zip:
54981
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-364-3605
Email:
ResearchDept@thedacare.org
Investigator:
Last name:
Matthias Weiss
Email:
Principal Investigator
Facility:
Name:
Aspirus Regional Cancer Center
Address:
City:
Wausau
Zip:
54401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-405-6866
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Facility:
Name:
Aspirus Cancer Care - Wisconsin Rapids
Address:
City:
Wisconsin Rapids
Zip:
54494
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
715-422-7718
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Start date:
July 19, 2024
Completion date:
June 1, 2026
Lead sponsor:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
National Cancer Institute (NCI)
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06096844
